MAKENZIE TILLER: Open Payments
NPI 1871089508 · SOUTH CHARLESTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,140 in 63 payments from 19 companies in 2025. Trend: 2023 $80 · 2024 $901 · 2025 $1,140
Food & beverage: $1,140
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $264 |
| ABBVIE INC. | 11 | $162 |
| Axsome Therapeutics, Inc. | 4 | $92 |
| Otsuka America Pharmaceutical, Inc. | 5 | $89 |
| Novartis Pharmaceuticals Corporation | 4 | $82 |
| AstraZeneca Pharmaceuticals LP | 4 | $64 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $52 |
| PFIZER INC. | 2 | $46 |
| Aimmune Therapeutics, Inc. | 2 | $40 |
| Sumitomo Pharma America, Inc. | 2 | $38 |
Products named: Ozempic, REXULTI, LEQVIO, QULIPTA, Auvelity, Kerendia, Wegovy, AIRSUPRA.
Industry payments across WV — which companies pay providers there.
